DV1 is a selective antagonist for CXC chemokine receptor 4 (CXCR4). DV1 exhibits antiviral activity by blocking HIV-1 entry through the CXCR4 co-receptor. DV1 is stable in rat plasma and exhibits good pharmacokinetic characteristics in rat models[1].
Molecular Weight:
2424.85
Formula:
C108H170N34O26S2
Target:
CXCR,HIV
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted